Allhat PowerPoint PPT Presentations

All Time
Show:
Recommended
Sort by:
ALLHAT PowerPoint PPT Presentation
ALLHAT - ALLHAT KLINIKA CHOR B WEWN TRZNYCH, NADCI NIENIA T TNICZEGO I ANGIOLOGII Agata Piaszczyk Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack ...
ALLHAT KLINIKA CHOR B WEWN TRZNYCH, NADCI NIENIA T TNICZEGO I ANGIOLOGII Agata Piaszczyk Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack ...
| PowerPoint PPT presentation | free to download
ALLHAT Antihypertensive Trial Results by Baseline Diabetic PowerPoint PPT Presentation
ALLHAT Antihypertensive Trial Results by Baseline Diabetic - ALLHAT Antihypertensive Trial Results by Baseline Diabetic & Fasting Glucose Status ... Diabetes Incidence (follow-up fasting glucose 126 mg/dL) ...
ALLHAT Antihypertensive Trial Results by Baseline Diabetic & Fasting Glucose Status ... Diabetes Incidence (follow-up fasting glucose 126 mg/dL) ...
| PowerPoint PPT presentation | free to view
ALLHAT: Optimal firststep therapy for hypertension PowerPoint PPT Presentation
ALLHAT: Optimal firststep therapy for hypertension - Eric J Topol MD. Provost and Chief Academic Officer ... PEACE and EUROPA are looking at ACE inhibitors as a key preventive tactic ' ...
Eric J Topol MD. Provost and Chief Academic Officer ... PEACE and EUROPA are looking at ACE inhibitors as a key preventive tactic ' ...
| PowerPoint PPT presentation | free to view
Validation of Heart Failure Events in ALLHAT Participants Assigned to Doxazosin and Chlorthalidone PowerPoint PPT Presentation
Validation of Heart Failure Events in ALLHAT Participants Assigned to Doxazosin and Chlorthalidone - ... Functional Classification of Congestive Heart Failure ... Hospitalized or Fatal Congestive Heart Failure Doxazosin/Chlorthalidone. ALLHAT. Conclusions (1) ...
... Functional Classification of Congestive Heart Failure ... Hospitalized or Fatal Congestive Heart Failure Doxazosin/Chlorthalidone. ALLHAT. Conclusions (1) ...
| PowerPoint PPT presentation | free to view
ALLHAT: What Outcomes Would Have Been Expected PowerPoint PPT Presentation
ALLHAT: What Outcomes Would Have Been Expected - 17 randomized, placebo-controlled trials using diuretic or b-blocker (n=48,000) ... Randomized Controlled Trials in Isolated Systolic Hypertension (ISH) ...
17 randomized, placebo-controlled trials using diuretic or b-blocker (n=48,000) ... Randomized Controlled Trials in Isolated Systolic Hypertension (ISH) ...
| PowerPoint PPT presentation | free to view
ALLHAT: What Outcomes Would Have Been Expected PowerPoint PPT Presentation
ALLHAT: What Outcomes Would Have Been Expected - ... of ACE Inhibition vs Placebo on CV Outcomes. Event Reduction in SHEP, Syst-Eur, ... Large Hypertension Trials Comparing Two or More Regimens: CVD or CV Mortality ...
... of ACE Inhibition vs Placebo on CV Outcomes. Event Reduction in SHEP, Syst-Eur, ... Large Hypertension Trials Comparing Two or More Regimens: CVD or CV Mortality ...
| PowerPoint PPT presentation | free to view
Has the publication of ALLHAT influenced the sale of diuretics PowerPoint PPT Presentation
Has the publication of ALLHAT influenced the sale of diuretics - The data source is IMS, Health ... Total Prescriptions. ALLHAT ... Source: IMS Health, National Prescription Audit PlusTM, 2003. Drug Utilization by Class ...
The data source is IMS, Health ... Total Prescriptions. ALLHAT ... Source: IMS Health, National Prescription Audit PlusTM, 2003. Drug Utilization by Class ...
| PowerPoint PPT presentation | free to view
Hypertension in the Elderly and Additional Data from the ALLHAT Study PowerPoint PPT Presentation
Hypertension in the Elderly and Additional Data from the ALLHAT Study - Hypertension in the Elderly and Additional Data from the ALLHAT Study William C. Cushman, MD, FACP Professor, Preventive Medicine and Medicine University of Tennessee
Hypertension in the Elderly and Additional Data from the ALLHAT Study William C. Cushman, MD, FACP Professor, Preventive Medicine and Medicine University of Tennessee
| PowerPoint PPT presentation | free to view
Implications of ASCOT Results for ALLHAT Conclusions PowerPoint PPT Presentation
Implications of ASCOT Results for ALLHAT Conclusions - ASCOT was not a comparison of initial treatment with newer drugs versus thiazide ... Even for total mortality, concomitant interventions can introduce confounding, ...
ASCOT was not a comparison of initial treatment with newer drugs versus thiazide ... Even for total mortality, concomitant interventions can introduce confounding, ...
| PowerPoint PPT presentation | free to view
Has the publication of ALLHAT influenced the sale of diuretics PowerPoint PPT Presentation
Has the publication of ALLHAT influenced the sale of diuretics - Has the publication of ALLHAT influenced the sale of diuretics
Has the publication of ALLHAT influenced the sale of diuretics
| PowerPoint PPT presentation | free to view
Improving Blood Pressure Treatment in the Community: A Joint Project of the NHBPEP and ALLHAT Collab PowerPoint PPT Presentation
Improving Blood Pressure Treatment in the Community: A Joint Project of the NHBPEP and ALLHAT Collab - Clinical Application and Prevention Program. Division of ... ALLHAT Dissemination Committee and the ALLHAT Clinical Trials Center revising proposal ...
Clinical Application and Prevention Program. Division of ... ALLHAT Dissemination Committee and the ALLHAT Clinical Trials Center revising proposal ...
| PowerPoint PPT presentation | free to view
How were stepup drugs selected and used in ALLHAT PowerPoint PPT Presentation
How were stepup drugs selected and used in ALLHAT - How were stepup drugs selected and used in ALLHAT
How were stepup drugs selected and used in ALLHAT
| PowerPoint PPT presentation | free to view
Angioedema in the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial ALLHAT PowerPoint PPT Presentation
Angioedema in the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial ALLHAT - Current/past smoker. 6 (75) 2 (67) 27 (73) 4 (80) ... Current smoker, n (%) 14 (37.8) 1981 (21.9) Hx. of diabetes, n (%) 4 (10.8) 3212 (35.5) ...
Current/past smoker. 6 (75) 2 (67) 27 (73) 4 (80) ... Current smoker, n (%) 14 (37.8) 1981 (21.9) Hx. of diabetes, n (%) 4 (10.8) 3212 (35.5) ...
| PowerPoint PPT presentation | free to view
Improving Blood Pressure Treatment in the Community: A Joint Project of the NHBPEP and ALLHAT Collab PowerPoint PPT Presentation
Improving Blood Pressure Treatment in the Community: A Joint Project of the NHBPEP and ALLHAT Collab - Improving Blood Pressure Treatment in the Community: A Joint Project of the ... 10,000 new randomized trials included in MEDLINE annually ...
Improving Blood Pressure Treatment in the Community: A Joint Project of the ... 10,000 new randomized trials included in MEDLINE annually ...
| PowerPoint PPT presentation | free to view
Validation of Heart Failure Events in ALLHAT Participants Assigned to Doxazosin and Chlorthalidone PowerPoint PPT Presentation
Validation of Heart Failure Events in ALLHAT Participants Assigned to Doxazosin and Chlorthalidone - New York Heart Association Functional Classification of Congestive Heart Failure ... physical activity without discomfort; symptoms at rest; increased discomfort ...
New York Heart Association Functional Classification of Congestive Heart Failure ... physical activity without discomfort; symptoms at rest; increased discomfort ...
| PowerPoint PPT presentation | free to view
Improving Blood Pressure Treatment in the Community: How the JNC7 Recommendations and ALLHAT Results PowerPoint PPT Presentation
Improving Blood Pressure Treatment in the Community: How the JNC7 Recommendations and ALLHAT Results - DBP significantly lower in the amlodipine group (~1 mm Hg), similar in the lisinopril group. ... 1/ 1,-2/ 0 amlodipine (HF only), lisinopril ...
DBP significantly lower in the amlodipine group (~1 mm Hg), similar in the lisinopril group. ... 1/ 1,-2/ 0 amlodipine (HF only), lisinopril ...
| PowerPoint PPT presentation | free to view
Improving Blood Pressure Treatment in the Community: How the JNC7 Recommendations and ALLHAT Results PowerPoint PPT Presentation
Improving Blood Pressure Treatment in the Community: How the JNC7 Recommendations and ALLHAT Results - Impact of New Results, Guidelines, & Traditional Approaches to Dissemination ... Initial drug therapy for most should be either thiazide-type diuretic alone or ...
Impact of New Results, Guidelines, & Traditional Approaches to Dissemination ... Initial drug therapy for most should be either thiazide-type diuretic alone or ...
| PowerPoint PPT presentation | free to view
The Importance of Blood Pressure Control in Diabetes PowerPoint PPT Presentation
The Importance of Blood Pressure Control in Diabetes - Favors Lisinopril. 1.11 (0.88-1.38) Favors Chlorthalidone. Amlodipine. Lisinopril. ALLHAT: Secondary Endpoints: ESRD. ALLHAT Collaborative Research Group. JAMA. ...
Favors Lisinopril. 1.11 (0.88-1.38) Favors Chlorthalidone. Amlodipine. Lisinopril. ALLHAT: Secondary Endpoints: ESRD. ALLHAT Collaborative Research Group. JAMA. ...
| PowerPoint PPT presentation | free to view
Essential Hypertension PowerPoint PPT Presentation
Essential Hypertension - ACC/AHA Post-MI Guideline, BHAT, SAVE, Capricorn, EPHESUS. ALLHAT, HOPE, ANBP2, LIFE, CONVINCE ... are contraindicated in pregnant women or those likely to ...
ACC/AHA Post-MI Guideline, BHAT, SAVE, Capricorn, EPHESUS. ALLHAT, HOPE, ANBP2, LIFE, CONVINCE ... are contraindicated in pregnant women or those likely to ...
| PowerPoint PPT presentation | free to view
Role of Diuretics in the Prevention of Heart Failure The Antihypertensive and LipidLowering Treatmen PowerPoint PPT Presentation
Role of Diuretics in the Prevention of Heart Failure The Antihypertensive and LipidLowering Treatmen - In 91% of HF cases, hypertension is an antecedent (Framingham, JAMA, 1996) ALLHAT ... Hypertension Control. and Heart Failure ...
In 91% of HF cases, hypertension is an antecedent (Framingham, JAMA, 1996) ALLHAT ... Hypertension Control. and Heart Failure ...
| PowerPoint PPT presentation | free to view
Major Outcomes in High Risk Hypertensive Patients Randomized to AngiotensinConverting Enzyme Inhibit PowerPoint PPT Presentation
Major Outcomes in High Risk Hypertensive Patients Randomized to AngiotensinConverting Enzyme Inhibit - Lisinopril 9,054. Chlorthalidone ... Lisinopril. 18. Stroke Subgroup Comparisons ... Lisinopril. 20. Cumulative Event Rates for Combined CVD by ALLHAT ...
Lisinopril 9,054. Chlorthalidone ... Lisinopril. 18. Stroke Subgroup Comparisons ... Lisinopril. 20. Cumulative Event Rates for Combined CVD by ALLHAT ...
| PowerPoint PPT presentation | free to view
Hypertension Chapter 15 PowerPoint PPT Presentation
Hypertension Chapter 15 - ALLHAT confirms 1st line role of thiazide diuretics ... Regular aerobic physical activity (at least 30 min/day, most days of the week) 4 9 ...
ALLHAT confirms 1st line role of thiazide diuretics ... Regular aerobic physical activity (at least 30 min/day, most days of the week) 4 9 ...
| PowerPoint PPT presentation | free to view
Diapositive 1 PowerPoint PPT Presentation
Diapositive 1 - ALLHAT conclue la sup riorit des diur tiques thiazidiques sur les IEC et inhibiteurs calciques ... lisinopril ou l alpha-bloquant doxazosine.
ALLHAT conclue la sup riorit des diur tiques thiazidiques sur les IEC et inhibiteurs calciques ... lisinopril ou l alpha-bloquant doxazosine.
| PowerPoint PPT presentation | free to download
Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihyperte PowerPoint PPT Presentation
Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihyperte - Blood Pressure Control ( 140/90 mm Hg) Rates in The United States in the 1990s ... lower in the amlodipine group (~1 mm Hg). ALLHAT. JAMA 2002;288:2981-2997 ...
Blood Pressure Control ( 140/90 mm Hg) Rates in The United States in the 1990s ... lower in the amlodipine group (~1 mm Hg). ALLHAT. JAMA 2002;288:2981-2997 ...
| PowerPoint PPT presentation | free to view
Major Outcomes in High Risk Hypertensive Patients Randomized to AngiotensinConverting Enzyme Inhibit PowerPoint PPT Presentation
Major Outcomes in High Risk Hypertensive Patients Randomized to AngiotensinConverting Enzyme Inhibit - Myocardial infarction or stroke: at least 6 months old, or age-indeterminate ... Mean age, y. Lisinopril 9,054. Chlorthalidone 15,255. ALLHAT. 20 ...
Myocardial infarction or stroke: at least 6 months old, or age-indeterminate ... Mean age, y. Lisinopril 9,054. Chlorthalidone 15,255. ALLHAT. 20 ...
| PowerPoint PPT presentation | free to view
What are the recent time trends in use of antihypertensive drugs PowerPoint PPT Presentation
What are the recent time trends in use of antihypertensive drugs - What are the recent time trends in use of antihypertensive drugs? ALLHAT ... Hypertension Treatment by Drug Class. Drug Utilization by Drug. IMS Health NDTI, 1978-2004 ...
What are the recent time trends in use of antihypertensive drugs? ALLHAT ... Hypertension Treatment by Drug Class. Drug Utilization by Drug. IMS Health NDTI, 1978-2004 ...
| PowerPoint PPT presentation | free to view
Why wasnt a betablocker tested as firstline therapy PowerPoint PPT Presentation
Why wasnt a betablocker tested as firstline therapy - Traditional drug choices considered diuretic, beta-blocker, or either/both. ... Concerns about beta-blockers in patients with diabetes (oversampled in ALLHAT) ...
Traditional drug choices considered diuretic, beta-blocker, or either/both. ... Concerns about beta-blockers in patients with diabetes (oversampled in ALLHAT) ...
| PowerPoint PPT presentation | free to view
Dissemination and Implementation PowerPoint PPT Presentation
Dissemination and Implementation - Physician. Report. Physician. Practice. ALLHAT. Rationale for ... Physician contact through NHBPEP member organizations. Formulary system approach ...
Physician. Report. Physician. Practice. ALLHAT. Rationale for ... Physician contact through NHBPEP member organizations. Formulary system approach ...
| PowerPoint PPT presentation | free to view
Can One Evaluate An Outcomes Claim Based On An Active Controlled Study? PowerPoint PPT Presentation
Can One Evaluate An Outcomes Claim Based On An Active Controlled Study? - ... were superior to first-line treatment with a diuretic (chlorthalidone) ... (Low-Dose Diuretic Studies) Amlodipine/Chlorthalidone. Chlorthalidone/Placebo. 16 ...
... were superior to first-line treatment with a diuretic (chlorthalidone) ... (Low-Dose Diuretic Studies) Amlodipine/Chlorthalidone. Chlorthalidone/Placebo. 16 ...
| PowerPoint PPT presentation | free to view
Clinical Trial Commentary PowerPoint PPT Presentation
Clinical Trial Commentary - ... or medicated for hypertension - at least one additional risk factor for coronary heart disease (CHD ... stroke, left ventricular hypertrophy by ECG or ...
... or medicated for hypertension - at least one additional risk factor for coronary heart disease (CHD ... stroke, left ventricular hypertrophy by ECG or ...
| PowerPoint PPT presentation | free to download
CV pharmacotherapy: Impact on newly diagnosed diabetes PowerPoint PPT Presentation
CV pharmacotherapy: Impact on newly diagnosed diabetes - of new diabetes. INVEST. ALPINE. SCOPE. CHARM. ANBP2. LIFE. HOPE ... Pepine CJ, Cooper-Dehoff RM. J Am Coll Cardiol. 2004;44:509-12. Sever PS et al. Lancet. ...
of new diabetes. INVEST. ALPINE. SCOPE. CHARM. ANBP2. LIFE. HOPE ... Pepine CJ, Cooper-Dehoff RM. J Am Coll Cardiol. 2004;44:509-12. Sever PS et al. Lancet. ...
| PowerPoint PPT presentation | free to view
SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY ANBP2 PowerPoint PPT Presentation
SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY ANBP2 - ACEI vs. thiazide-type diuretic, n = 24,309 vs. 6,083. Number of patients with events ... SBP slightly lower with diuretic in both trials. 6. CONCLUSIONS ...
ACEI vs. thiazide-type diuretic, n = 24,309 vs. 6,083. Number of patients with events ... SBP slightly lower with diuretic in both trials. 6. CONCLUSIONS ...
| PowerPoint PPT presentation | free to view
Setting the Record Straight PowerPoint PPT Presentation
Setting the Record Straight - Diuretics drug of choice for initial therapy of HTN and should be included in ... Caution when using -blockers in combination therapy. Conclusions & Interpretations ...
Diuretics drug of choice for initial therapy of HTN and should be included in ... Caution when using -blockers in combination therapy. Conclusions & Interpretations ...
| PowerPoint PPT presentation | free to view
Treatment Of Hypertensive Patients With Dyslipidemia And The Metabolic Syndrome: Update from the ALL PowerPoint PPT Presentation
Treatment Of Hypertensive Patients With Dyslipidemia And The Metabolic Syndrome: Update from the ALL - Lisinopril. Estimated GFR mL/min/1.73m2 ,mean (SD) Serum potassium mmol/L, mean (SD) ... Lisinopril / Chlorthalidone. Amlodipine / Chlorthalidone ...
Lisinopril. Estimated GFR mL/min/1.73m2 ,mean (SD) Serum potassium mmol/L, mean (SD) ... Lisinopril / Chlorthalidone. Amlodipine / Chlorthalidone ...
| PowerPoint PPT presentation | free to view
NICE/BHS Hypertension Guideline Review 28 June 2006 PowerPoint PPT Presentation
NICE/BHS Hypertension Guideline Review 28 June 2006 - NICE/BHS Hypertension Guideline Review 28 June 2006 John Barker
NICE/BHS Hypertension Guideline Review 28 June 2006 John Barker
| PowerPoint PPT presentation | free to download
HYPERTENSION When, what, co-morbid conditions ? PowerPoint PPT Presentation
HYPERTENSION When, what, co-morbid conditions ? - Title: HYPERTENSION Recent Tirals Update Subject: Recent HT Trials Author: George Mangos Keywords: target, observational data Last modified by: George
Title: HYPERTENSION Recent Tirals Update Subject: Recent HT Trials Author: George Mangos Keywords: target, observational data Last modified by: George
| PowerPoint PPT presentation | free to view
Main Trial Design and Trial Status PowerPoint PPT Presentation
Main Trial Design and Trial Status - Main Trial Design and Trial Status Walter T. Ambrosius, PhD SPRINT Coordinating Center Wake Forest School of Medicine American Society of Hypertension, Inc. (ASH ...
Main Trial Design and Trial Status Walter T. Ambrosius, PhD SPRINT Coordinating Center Wake Forest School of Medicine American Society of Hypertension, Inc. (ASH ...
| PowerPoint PPT presentation | free to download
Do the SBP differences between the lisinopril and chlorthalidone arms explain the differences in CVD PowerPoint PPT Presentation
Do the SBP differences between the lisinopril and chlorthalidone arms explain the differences in CVD - ... the SBP differences between the lisinopril and chlorthalidone arms explain the ... BP differences: lisinopril versus chlorthalidone (continued) ...
... the SBP differences between the lisinopril and chlorthalidone arms explain the ... BP differences: lisinopril versus chlorthalidone (continued) ...
| PowerPoint PPT presentation | free to view
Ethnic influences on stroke risk PowerPoint PPT Presentation
Ethnic influences on stroke risk - Ethnic influences on stroke risk Francesco P Cappuccio MD MSc FRCP FFPH
Ethnic influences on stroke risk Francesco P Cappuccio MD MSc FRCP FFPH
| PowerPoint PPT presentation | free to download
??????????? ????? ???????????? ??????? ?? PowerPoint PPT Presentation
??????????? ????? ???????????? ??????? ?? - The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) PowerPoint , ...
The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) PowerPoint , ...
| PowerPoint PPT presentation | free to download
Major Outcomes in High Risk Hypertensive Patients Randomized to AngiotensinConverting Enzyme Inhibit PowerPoint PPT Presentation
Major Outcomes in High Risk Hypertensive Patients Randomized to AngiotensinConverting Enzyme Inhibit - Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin ... 30% were on 1 drug and controlled. 12. Biochemical Results. 93 (1.9) 707 (8.5) 4 Years ...
Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin ... 30% were on 1 drug and controlled. 12. Biochemical Results. 93 (1.9) 707 (8.5) 4 Years ...
| PowerPoint PPT presentation | free to view
JNC 7: Update on the Management of Hypertension PowerPoint PPT Presentation
JNC 7: Update on the Management of Hypertension - Mean intake: Men 4100 mg; Women 2750 mg. 75% from processed foods ... ACC/AHA Post-MI Guideline, BHAT, SAVE, Capricorn, EPHESUS. BB, ACEI. Postmyocardial ...
Mean intake: Men 4100 mg; Women 2750 mg. 75% from processed foods ... ACC/AHA Post-MI Guideline, BHAT, SAVE, Capricorn, EPHESUS. BB, ACEI. Postmyocardial ...
| PowerPoint PPT presentation | free to view
National Trends in the Prescribing of Anti-Hypertensive Medications PowerPoint PPT Presentation
National Trends in the Prescribing of Anti-Hypertensive Medications - Practice guidelines aim to guide physician practice according to the best available evidence ... Physician-reported data on new and continuing medications for ...
Practice guidelines aim to guide physician practice according to the best available evidence ... Physician-reported data on new and continuing medications for ...
| PowerPoint PPT presentation | free to view
Hypertension PowerPoint PPT Presentation
Hypertension - Hypertension The treatment of hypertension is the most common reason for office ... the overall impact of moderate sodium reduction is a fall in blood pressure ...
Hypertension The treatment of hypertension is the most common reason for office ... the overall impact of moderate sodium reduction is a fall in blood pressure ...
| PowerPoint PPT presentation | free to view
New Frontiers in CVD Risk Management: Optimizing Outcomes in Patients with Multiple Cardiovascular Risks PowerPoint PPT Presentation
New Frontiers in CVD Risk Management: Optimizing Outcomes in Patients with Multiple Cardiovascular Risks - New Frontiers in CVD Risk Management: Optimizing Outcomes in Patients with Multiple Cardiovascular Risks
New Frontiers in CVD Risk Management: Optimizing Outcomes in Patients with Multiple Cardiovascular Risks
| PowerPoint PPT presentation | free to view
Blood Pressure Control in Hispanics in the Antihypertensive and Lipidlowering Treatment to Prevent H PowerPoint PPT Presentation
Blood Pressure Control in Hispanics in the Antihypertensive and Lipidlowering Treatment to Prevent H - Changes in Hypertension Awareness, Treatment, and Control ... Other renal (reciprocal serum creatinine, ESRD, estimated GFR), diabetes, and cancer ...
Changes in Hypertension Awareness, Treatment, and Control ... Other renal (reciprocal serum creatinine, ESRD, estimated GFR), diabetes, and cancer ...
| PowerPoint PPT presentation | free to view
Fasting Glucose Levels PowerPoint PPT Presentation
Fasting Glucose Levels - Among participants who are non-diabetic at baseline: ... (Adjusted for age, gender, race, smoking, BMI, and fasting glucose, SBP, and DBP at baseline a ) ...
Among participants who are non-diabetic at baseline: ... (Adjusted for age, gender, race, smoking, BMI, and fasting glucose, SBP, and DBP at baseline a ) ...
| PowerPoint PPT presentation | free to view
Diuretics, Potassium, Glucose Intolerance, and CVD Risk PowerPoint PPT Presentation
Diuretics, Potassium, Glucose Intolerance, and CVD Risk - What are the implications of differences in 'new diabetes' ... in treatment group effect by baseline history of diabetes. ... Diabetes at baseline signif. ...
What are the implications of differences in 'new diabetes' ... in treatment group effect by baseline history of diabetes. ... Diabetes at baseline signif. ...
| PowerPoint PPT presentation | free to view
Synergistic actions of hypertension and dyslipidemia on endothelial function PowerPoint PPT Presentation
Synergistic actions of hypertension and dyslipidemia on endothelial function - Title: PowerPoint Presentation Author: Medical Education Consultants, LLC Last modified by: William Tryon Created Date: 6/7/2004 4:56:07 PM Document presentation format
Title: PowerPoint Presentation Author: Medical Education Consultants, LLC Last modified by: William Tryon Created Date: 6/7/2004 4:56:07 PM Document presentation format
| PowerPoint PPT presentation | free to view
Faut-il traiter par statines tous les patients PowerPoint PPT Presentation
Faut-il traiter par statines tous les patients - Reste-t-il des patients risque vasculaire qu'il ne faut pas encore traiter par ... Ce qui est acquis. Pr vention secondaire chez le coronarien (4S, CARE, ...
Reste-t-il des patients risque vasculaire qu'il ne faut pas encore traiter par ... Ce qui est acquis. Pr vention secondaire chez le coronarien (4S, CARE, ...
| PowerPoint PPT presentation | free to view
Outcomes in Hypertensive Black and Nonblack Patients Treated with Chlorthalidone, Amlodipine, and Li PowerPoint PPT Presentation
Outcomes in Hypertensive Black and Nonblack Patients Treated with Chlorthalidone, Amlodipine, and Li - Impaired fasting glucose. 56.2. 49.9. Normoglycemic. 12.3. 23.9 ... Fasting Glucose (mean mg/dl) by Treatment Group and Race. 120. 123. 125. 4 Years. 119. 120 ...
Impaired fasting glucose. 56.2. 49.9. Normoglycemic. 12.3. 23.9 ... Fasting Glucose (mean mg/dl) by Treatment Group and Race. 120. 123. 125. 4 Years. 119. 120 ...
| PowerPoint PPT presentation | free to view
The Importance of Blood Pressure Control in Preventing Cardiovascular Disease PowerPoint PPT Presentation
The Importance of Blood Pressure Control in Preventing Cardiovascular Disease - MRFIT screenees- 356,222 men, age 35-37 yrs at baseline with 6 yrs of f/u. Stamler J. ... ACC/AHA Post-MI Guideline, BHAT, SAVE, Capricorn, EPHESUS ...
MRFIT screenees- 356,222 men, age 35-37 yrs at baseline with 6 yrs of f/u. Stamler J. ... ACC/AHA Post-MI Guideline, BHAT, SAVE, Capricorn, EPHESUS ...
| PowerPoint PPT presentation | free to view
DIURETICS: PowerPoint PPT Presentation
DIURETICS: - Davidoff 09 DIURETICS: (know those used to Tx hypertension and HF) Thiazide diuretics: hydrochlorothiazide Loop diuretics: furosemide, ethacrynic acid
Davidoff 09 DIURETICS: (know those used to Tx hypertension and HF) Thiazide diuretics: hydrochlorothiazide Loop diuretics: furosemide, ethacrynic acid
| PowerPoint PPT presentation | free to download
Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin v PowerPoint PPT Presentation
Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin v - Women. African-Americans. Type 2 Diabetes. Major Subgroups (post ... Differences between event curves. log-rank tests & Cox proportional. hazards (PH) model ...
Women. African-Americans. Type 2 Diabetes. Major Subgroups (post ... Differences between event curves. log-rank tests & Cox proportional. hazards (PH) model ...
| PowerPoint PPT presentation | free to view
CONFUSING MESSAGES FROM GUIDELINES AND THE HYPERTENSION TREATMENT TRIALS PowerPoint PPT Presentation
CONFUSING MESSAGES FROM GUIDELINES AND THE HYPERTENSION TREATMENT TRIALS - regime based on a CCB /- an ACE inhibitor ... ACE inhibitors. B-Blockers. Calcium channel blockers. Vasodilators 1 Agent without thiazide ...
regime based on a CCB /- an ACE inhibitor ... ACE inhibitors. B-Blockers. Calcium channel blockers. Vasodilators 1 Agent without thiazide ...
| PowerPoint PPT presentation | free to view


Home About Us Terms and Conditions Privacy Policy Contact Us
Copyright 2024 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
allhat — Search results on PowerShow.com